drugset / Trial / NCT01515566

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

NCT01515566

Phase 1/2 Completed 26 enrolled M.D. Anderson Cancer Center
RandomizedParallel-groupDouble-blindSupportive care

Summary

The goal of this clinical research study is to learn if fentanyl given under the skin can reduce shortness of breath in cancer patients. Researchers also want to learn if it can help to improve your physical function. In this study, fentanyl will be compared to a placebo. Fentanyl is commonly used for treatment of cancer pain. It is believed to help patients with their shortness of breath as well. A placebo is not a drug. It looks like the study drug but is not designed to treat any disease or illness. It is designed to be compared with a study drug to learn if the study drug has any real effect.

Timeline

Start
2012-04
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified Subcutaneous

Indications

No indication recorded.